Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × COVID-19 × palbociclib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Sarcoma 1 Prostatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Follicular 1 Fallopian Tube Neoplasms 1 Estrogen Receptor Positive 1 Colorectal Neoplasms 1 Carcinoma, Endometrioid 1 COVID-19 1 Brain Neoplasms 1 Adenocarcinoma of Lung 1

Interventions

Standard of Care 2 tocilizumab 1 remdesivir 1 palbociclib 1 ogalvibart 1 crexavibart 1 cilgavimab and tixagevimab drug combination 1 Practice Guidelines as Topic 1 Immunoglobulin G 1 Hydroxychloroquine 1 Disulfides 1 Blood Specimen Collection 1 Azithromycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05371275 2022-11-07

CDK6COV

biotx.ai GmbH

Phase 2 Withdrawn

COVID-19, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡